Veterinary Medicines

NOBILIS IB Ma5

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Download as PDF

Product identification

Medicine name:
NOBILIS IB Ma5
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Target species:
  • Chicken (chick)
Route of administration:
  • Oculonasal use
  • In drinking water use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
    3.00
    log 10 50% embryo infective dose
    /
    0.03
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken (chick)
  • In drinking water use
    • Chicken (chick)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Intervet Romania S.R.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 150161
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 3/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."